Ulcerative Colitis Treatment

Jul 12, 2024

Top 7 Breakthrough Drugs for Ulcerative Colitis Treatment

Oct 20, 2023

New Player in Ulcerative Colitis Treatment: Pfizer’s Etrasimod Entry Counters BMS’ Zeposia

Dec 27, 2022

Gilead Sciences’ Sunlenca Approval; FDA Approves Roche’s CD20xCD3 Bispecific Antibody Lunsumio; EU Approves AstraZeneca’s Imfinzi Plus Chemo; Pfizer Files Blockbuster Hope Etrasimod for Ulcerative Colitis; FDA Approves Mosunetuzumab for R/F Follicular Lymphoma; FDA Breakthrough Therapy Designation to Adagrasib Plus Cetuximab for KRAS G12C–Mutated Advanced CRC

Sep 23, 2022

How the Novel Emerging Therapies Will Reshuffle the Ulcerative Colitis Treatment Dynamics?

May 26, 2020

Algernon’s NP-120; FDA nod to 4DMedical tool; SaNOtize’s NORSTM trial; Pole’s capital increase

Newsletter/Whitepaper